Sanofi v Amgen Inc. (No 2) [2023] FCA 1156
Federal Court appeal from patent opposition decision – application to limit overlapping evidence from experts with same expertise – application to limit overlapping evidence in declarations lodged in the patent office to the extent already addressed in supplementary affidavits from the same expert witness.